X

Stay Connected

Sign Up for Updates

We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.

Case Study: How one online pharmacy knowingly endangered U.S. consumers

By Nicole Longo  |    March 2, 2017
We recently looked at what actually happens when a patient orders a medicine through an online Canadian pharmacy and how the product delivered may not be what the patient ordered. Today, we’re...   Read More

Why drug importation threatens patient safety

By Allyson Funk  |    February 28, 2017
Counterfeit drug manufacturing and trafficking is a multi-billion dollar business. Legislative proposals to allow importation of potentially counterfeit and substandard drugs into the United...   Read More

Fact Check Friday: The truth about drug importation and patient safety

By Allyson Funk  |    February 24, 2017
This week on Fact Check Friday, we’re discussing the truth about proposals to allow the importation of medicines from other countries and what these proposals mean for patients. MYTH: Importation...   Read More

What you don’t know about importation from Canada

By Allyson Funk  |    February 17, 2017
Proposals to allow the importation of prescription medicines from Canada ignore the dangerous threat to patients of counterfeit and adulterated medicines. What actually happens when a patient...   Read More

Discovery of counterfeit hepatitis C drug is another example of why importation is bad for patients

By Nicole Longo  |    February 13, 2017
The manufacturing and trafficking of counterfeit drugs is not just a U.S. concern but a growing threat globally. Governments around the world are working together to try to prevent these fake...   Read More

New report provides recommendations for securing and protecting IP

By Mark Grayson  |    December 13, 2016
This week, the White House Office of the U.S. Intellectual Property Enforcement Coordinator (IPEC) issued a Joint Strategic Plan outlining actions government, industry, educational institutions...   Read More

Dangers of drug importation: A case of counterfeit cancer drugs

By Holly Campbell  |    April 7, 2016
Counterfeit drug trafficking is a multibillion dollar business that threatens the health and well-being of patients. The World Health Organization estimates 10 percent of medicines worldwide are...   Read More

More Counterfeit Medicines Follow-up

By PhRMA Staff  |    March 14, 2011
The Hill reports that Senate Judiciary Committee Chairman Patrick Leahy (D-VT) recommitted himself to helping stop the flow of counterfeit medicines into the U.S. Here's some of what Leahy had to say:   Read More

Protecting Patients From Dangerous Counterfeit Drugs

By PhRMA Staff  |    March 13, 2011
There was a recent article on MarketWatch that caught my eye because it really broke down the issue of counterfeiting and the dangers that rogue online pharmacy sites pose to patient health and...   Read More

Foreign Sourced Active Pharmaceutical Ingredients vs. Imported Drugs

By PhRMA Staff  |    March 12, 2011
In a 60 Minutes segment airing tonight, Food and Drug Administration (FDA) Commissioner Margaret Hamburg admits that there are rare instances of counterfeit medicines seeping into the closed U.S drug...   Read More

Search the Catalyst

View Posts by Topic

see all

Subscribe to Email Updates